Skip to main content
. 2024 Feb 13;16(4):774. doi: 10.3390/cancers16040774

Figure 2.

Figure 2

Distribution of MGA scores. (A) In the MMP cohort (n = 526), 36.3% of patients (n = 191) were classified as high risk (MMP index < 0). (B) In the ODX cohort (n = 2039), 14.3% of patients (n = 297) were classified as high risk (ODX risk score > 25). MGA, multi-gene assay; MMP, Mammaprint; ODX, Oncotype DX.